HuGE Literature Finder
Records
1
-
30
| High BM plasma S100A8/A9 is associated with a perturbed microenvironment and poor prognosis in myelodysplastic syndromes. Blood advances 2023 1 . Wang Yu-Hung, Lin Chien-Chin, Yao Chi-Yuan, Amaral Fabio, Yu Shan-Chi, Kao Chein-Jun, Shih Pin-Tsen, Hou Hsin-An, Chou Wen-Chien, Tien Hwei-Fa |
| ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial. International journal of hematology 2022 7 116 (5): 659-668. Morita Yasuyoshi, Nannya Yasuhito, Ichikawa Motoshi, Hanamoto Hitoshi, Shibayama Hirohiko, Maeda Yoshinobu, Hata Tomoko, Miyamoto Toshihiro, Kawabata Hiroshi, Takeuchi Kazuto, Tanaka Hiroko, Kishimoto Junji, Miyano Satoru, Matsumura Itaru, Ogawa Seishi, Akashi Koichi, Kanakura Yuzuru, Mitani Kinu |
| Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management. American journal of hematology 2022 1 97 (3): 352-372. Patnaik Mrinal M, Tefferi Ayal |
| Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes. Scientific reports 2022 4 12 (1): 5925. Maurya Nehakumari, Mohanty Purvi, Dhangar Somprakash, Panchal Purvi, Jijina Farah, Mathan S Leo Prince, Shanmukhaiah Chandrakala, Madkaikar Manisha, Vundinti Babu R |
| Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes. Hematological oncology 2022 11 . Lee Wan-Hsuan, Lin Chien-Chin, Wang Yu-Hung, Yao Chi-Yuan, Kuo Yuan-Yeh, Tseng Mei-Hsuan, Peng Yen-Ling, Hsu Cheng-An, Sun Hsun-I, Chuang Yi-Kuang, Hsu Chia-Lang, Tien Feng-Ming, Tsai Cheng-Hong, Chou Wen-Chien, Hou Hsin-An, Tien Hwei-Fa |
| Genetic mutations associated with blood count abnormalities in myeloid neoplasms. Hematology (Amsterdam, Netherlands) 2022 6 27 (1): 765-771. Polprasert Chantana, Kongkiatkamon Sunisa, Niparuck Pimjai, Rattanathammethee Thanawat, Wudhikarn Kitsada, Chuncharunee Suporn, Kobbuaklee Sirorat, Suksusut Amornchai, Lanamtieng Theerin, Lawasut Panisinee, Asawapanumas Thiti, Bunworasate Udomsak, Rojnuckarin Ponlap |
| Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience. Frontiers in oncology 2022 4 12 795955. Fattizzo Bruno, Levati Giorgia Virginia, Giannotta Juri Alessandro, Cassanello Giulio, Cro Lilla Marcella, Zaninoni Anna, Barbieri Marzia, Croci Giorgio Alberto, Revelli Nicoletta, Barcellini Wil |
| New genetic variants of TET2 and ASXL1 identified by next generation sequencing and pyrosequencing in a patient with MDS-RS-MLD and secondary acute myeloid leukemia. Central-European journal of immunology 2022 2 46 (4): 524-530. Adamska Monika Ma?gorzata, Kowal-Wi?niewska Ewelina, Kiwerska Katarzyna, Ustaszewski Adam, Czerwi?ska-Rybak Joanna, Kandu?a Zuzanna, Wojtaszewska Marzena, Bara?ska Marta, Pruchniewski ?ukasz, Lewandowski Krzysztof, Jarmu?-Szymczak Ma?gorzata, Gil Lid |
| Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum. Blood advances 2022 6 6 (13): 3921-3931. Calvo Xavier, Roman-Bravo David, Garcia-Gisbert Nieves, Rodriguez-Sevilla Juan Jose, Garcia-Avila Sara, Florensa Lourdes, Gibert Joan, Fernández-Rodríguez Concepción, Salido Marta, Puiggros Anna, Espinet Blanca, Colomo Luis, Bellosillo Beatriz, Ferrer Ana, Arenillas Leon |
| Prognostic value of ASXL1 mutations in patients with myelodysplastic syndromes and acute myeloid leukemia: A meta-analysis. Asia-Pacific journal of clinical oncology 2022 12 . Zhang Ao, Wang Shuxing, Ren Quanlei, Wang Yizhu, Jiang Zhipi |
| [Characteristics and Clinical Significance of Gene Mutation in Patients with Myelodysplastic Syndrome]. Zhongguo shi yan xue ye xue za zhi 2021 12 29 (6): 1864-1868. Zhao Fang, Wang Kai-Li, Qin Yu-Ting, Nilupar Tuerxun, Patiguli Abulizi, Jiang Ming, Hao Jian-Pi |
| [Predisposition and progression of myelodysplastic syndromes]. [Rinsho ketsueki] The Japanese journal of clinical hematology 2021 5 62 (4): 278-288. Makishima Hide |
| Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes. Blood advances 2021 2 5 (4): 1017-1028. Hunter Anthony M, Komrokji Rami S, Yun Seongseok, Al Ali Najla, Chan Onyee, Song Jinming, Hussaini Mohammad, Talati Chetasi, Sweet Kendra L, Lancet Jeffrey E, Padron Eric, List Alan F, Sallman David |
| Have we reached a molecular era in myelodysplastic syndromes? Hematology. American Society of Hematology. Education Program 2021 12 2021 (1): 418-427. Voso Maria Teresa, Gurnari Carme |
| Mutations in chronic myelomonocytic leukemia and their prognostic relevance. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 4 23 (9): 1731-1742. Jian J, Qiao Y, Li Y, Guo Y, Ma H, Liu |
| Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations. British journal of haematology 2021 7 194 (4): 708-717. Martín Iván, Villamón Eva, Abellán Rosario, Calasanz Maria José, Irigoyen Aroa, Sanz Guillermo, Such Esperanza, Mora Elvira, Gutiérrez Míriam, Collado Rosa, García-Serra Rocío, Vara Míriam, Blanco Mª Laura, Oiartzabal Itziar, Álvarez Sara, Bernal Teresa, Granada Isabel, Xicoy Blanca, Jerez Andrés, Calabuig Marisa, Diez Rosana, Gil Ángela, Díez-Campelo María, Solano Carlos, Tormo Mar, |
| Prediction of Response to Erythropoiesis Stimulating Agents in Low-Risk Myelodysplastic Syndromes. Asian Pacific journal of cancer prevention : APJCP 2021 12 22 (12): 4037-4042. Hattakitpanitchakul Saroj, Kobbuaklee Sirorat, Wudhikarn Kitsada, Polprasert Chanta |
| The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm. International journal of laboratory hematology 2021 7 43 (6): 1501-1509. Ibrar Warda, Zhang Weiwei, Cox Jesse Lee, Cushman-Vokoun Allison, Fu Kai, Greiner Timothy C, Yuan |
| Utility of plasma cell-free DNA for de novo detection and quantification of clonal hematopoiesis. Haematologica 2021 9 107 (8): 1815-1826. Gutierrez-Rodrigues Fernanda, Beerman Isabel, Groarke Emma M, Patel Bhavisha A, Spitofsky Nina, Dillon Laura W, Raffo Diego Quinones, Hourigan Christopher S, Kajigaya Sachiko, Ferrucci Luigi, Young Neal |
| [Correlation between U2AF1 Gene Mutation Characteristics and Clinical Manifestations and Prognosis in Patients with Myelodysplastic Syndrome]. Zhongguo shi yan xue ye xue za zhi 2020 Dec 28 (6): 1977-1984. Zhao Wen-Shu, Zhang Yin-Tian, Jiang Qian-Li, Liu Qi-Fa, Dai M |
| Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results. Blood advances 2020 May 4 (9): 1942-1949. Gardin Claude, Pautas Cécile, Fournier Elise, Itzykson Raphaël, Lemasle Emilie, Bourhis Jean-Henri, Adès Lionel, Marolleau Jean-Pierre, Malfuson Jean-Valère, Gastaud Lauris, Raffoux Emmanuel, Lambert Juliette, Braun Thorsten, Thomas Xavier, Chantepie Sylvain, Cluzeau Thomas, de Botton Stéphane, Berthon Céline, Boissel Nicolas, Duployez Nicolas, Terré Christine, Peffault de Latour Régis, Michallet Mauricette, Celli-Lebras Karine, Preudhomme Claude, Dombret Her |
| [Features and clinical significance of gene mutations in patients with myelodysplastic syndromes with ring sideroblasts]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2020 6 41 (5): 379-386. Cai Y N, Xu Z F, Li B, Qin T J, Pan L J, Qu S Q, Hu N B, Liu D, Huang H J, Shi Z X, Zhang Y D, Xiao Z |
| Clinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutations. Journal of clinical pathology 2020 3 73 (11): 728-736. Liu Yen-Chun, Illar Gwendolyn M, Bailey Nathanael Gl |
| Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation. Hematology (Amsterdam, Netherlands) 2020 6 25 (1): 211-218. Wang Kai, Zhou Feng, Cai Xiaohui, Chao Hongying, Zhang Ri, Chen Suni |
| The expression levels of long non-coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes. British journal of haematology 2020 11 192 (3): 589-598. Hung Sheng-Yu, Lin Chien-Chin, Hsu Chia-Lang, Yao Chi-Yuan, Wang Yu-Hung, Tsai Cheng-Hong, Hou Hsin-An, Chou Wen-Chien, Tien Hwei-Fa |
| Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes. Cancer science 2019 Dec . Jiang Lingxu, Luo Yingwan, Zhu Shuanghong, Wang Lu, Ma Liya, Zhang Hua, Shen Chuying, Yang Wenli, Ren Yanling, Zhou Xinping, Mei Chen, Ye Li, Xu Weilai, Yang Haiyang, Lu Chenxi, Jin Jie, Tong Hongy |
Non-del(5q) myelodysplastic syndromes-associated loci detected by SNP-array genome-wide association meta-analysis.
Blood advances 2019 Nov 3 (22): 3579-3589. McGraw Kathy L, Cheng Chia-Ho, Chen Y Ann, Hou Hsin-An, Nilsson Björn, Genovese Giulio, Cluzeau Thomas, Pellagatti Andrea, Przychodzen Bartlomiej P, Mallo Mar, Arenillas Leonor, Mohamedali Azim, Adès Lionel, Sallman David A, Padron Eric, Sokol Lubomir, Moreilhon Chimene, Raynaud Sophie, Tien Hwei-Fang, Boultwood Jacqueline, Ebert Benjamin L, Sole Francesc, Fenaux Pierre, Mufti Ghulam J, Maciejewski Jaroslaw P, Kanetsky Peter A, List Alan |
| Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern. Blood advances 2019 Oct 3 (20): 3111-3122. Berger Gerbrig, Gerritsen Mylene, Yi Guoqiang, Koorenhof-Scheele Theresia N, Kroeze Leonie I, Stevens-Kroef Marian, Yoshida Kenichi, Shiraishi Yuichi, van den Berg Eva, Schepers Hein, Huls Geert, Mulder André B, Ogawa Seishi, Martens Joost H A, Jansen Joop H, Vellenga E |
| [Analysis of mutations of 14 genes among 87 patients with myelodysplastic syndrome]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2019 10 36 (10): 953-956. Zhou Xuyan, Jin He, Mu Qitian, Sheng Lixia, Lai Binbin, Zhu Huiling, Ouyang Guifa |
| Concurrent mutations in other epigenetic modulators portend better prognosis in BCOR-mutated myelodysplastic syndrome. Journal of clinical pathology 2019 11 73 (4): 209-212. Badaat Ibraahim, Mirza Sabbir, Padron Eric, Sallman David, Komrokji Rami, Song Jinming, Hussaini Mohammad |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 20, 2023
- Content source: